| IBRX Stock | | | USD 5.10 0.02 0.39% |
Immunitybio financial indicator trend analysis is infinitely more than just investigating Immunitybio recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunitybio is a good investment. Please check the relationship between Immunitybio Total Assets and its Cash accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunitybio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Immunitybio Stock please use our
How to Invest in Immunitybio guide.
Total Assets vs Cash
Total Assets vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Immunitybio Total Assets account and
Cash. At this time, the significance of the direction appears to have strong relationship.
The correlation between Immunitybio's Total Assets and Cash is 0.75. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Cash in the same time period over historical financial statements of Immunitybio, assuming nothing else is changed. The correlation between historical values of Immunitybio's Total Assets and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Immunitybio are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Total Assets i.e., Immunitybio's Total Assets and Cash go up and down completely randomly.
Correlation Coefficient | 0.75 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Total Assets
Total assets refers to the total amount of Immunitybio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Immunitybio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Cash
Cash refers to the most liquid asset of Immunitybio, which is listed under current asset account on Immunitybio balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Immunitybio customers. The amounts must be unrestricted with restricted cash listed in a different Immunitybio account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most indicators from Immunitybio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunitybio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunitybio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Immunitybio Stock please use our
How to Invest in Immunitybio guide.At this time, Immunitybio's
Tax Provision is fairly stable compared to the past year.
Sales General And Administrative To Revenue is likely to rise to 802.07 in 2024, whereas
Selling General Administrative is likely to drop slightly above 91.7
M in 2024.
Immunitybio fundamental ratios Correlations
Click cells to compare fundamentals
Immunitybio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Immunitybio fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Immunitybio Stock Analysis
When running Immunitybio's price analysis, check to
measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to
predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.